Comparison of the Effect Between Levofloxacin and Moxifloxacin Among MDR-TB Patients
Status:
Terminated
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
Fluoroquinolone is a one of the most important drugs for treatment of multidrug-resistant TB
(MDR-TB). Among them, levofloxacin and moxifloxacin has been used most widely. However, there
is no study to directly compare the efficacy of levofloxacin and moxifloxacin among MDR-TB
patients. The investigators will compare the efficacy of levofloxacin and moxifloxacin
through a prospective multicenter randomized open label phase III trial.
Phase:
Phase 3
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Fluoroquinolones Levofloxacin Moxifloxacin Norgestimate, ethinyl estradiol drug combination Ofloxacin